Mabwell
Alphabet’s Calico Strikes $596M Deal for Mabwell’s Anti-Aging Antibody
Calico; Alphabet; Mabwell; anti-aging; biotech; IL-11 antibody; 9MW3811; exclusive licensing; aging-related diseases; biopharma deal
Actionable Insights Powered by AI
Calico; Alphabet; Mabwell; anti-aging; biotech; IL-11 antibody; 9MW3811; exclusive licensing; aging-related diseases; biopharma deal